Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Does Maternal Body Mass Index Affect the Quantity of Circulating Fetal Cells Available to Use for Cell-Based Noninvasive Prenatal Test in High-Risk Pregnancies?

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Cell-Free Fetal DNA in the Early and Late First Trimester

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Short-Term Flow Changes in Monochorionic Survivor Twins after Ultrasound-Guided Umbilical Cord Occlusion

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Magnetic Resonance Imaging: A New Tool to Optimize the Prediction of Fetal Anemia?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Current use of noninvasive prenatal testing in Europe, Australia and the USA: A graphical presentation

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Implementation of exome sequencing in fetal diagnostics - data and experiences from a tertiary center in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. "It's probably nothing, but…" Couples' experiences of pregnancy following an uncertain prenatal genetic result

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Nuchal translucency of 3.0-3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Sofie Kruckow
  • Palle schelde
  • Lotte Hatt
  • katarina ravn
  • Olav Bjørn Petersen
  • Niels Uldbjerg
  • Ida Vogel
  • Singh Ripudaman
View graph of relations

We present the first study that investigates the effect of maternal body mass index (BMI) on the quantity of circulating fetal cells available to use in cell-based noninvasive prenatal test (cbNIPT). cbNIPT has been proposed as a superior alternative to noninvasive prenatal test from cell-free fetal DNA. Kølvraa et al. [Prenat Diagn. 2016 Dec; 36(12): 1127-34] established that cbNIPT can be performed on as few as one fetal cell, and Vestergaard et al. [Prenat Diagn. 2017 Nov; 37(11): 1120-4] demonstrated that these fetal trophoblast cells could be used successfully in cbNIPT to detect chromosomal and sub-chromosomal abnormalities. This study on 91 pregnant women with high-risk pregnancies suggests that cbNIPT should not be hampered by an increased BMI because every pregnancy, irrespective of the BMI, has rendered fetal cells for downstream genetic analysis. The mean number of fetal cells per sample was 12.6, with a range of 1-43 cells in one sample. ANOVA showed that increasing maternal BMI tends to decrease the number of fetal cells, but not significantly.

Original languageEnglish
JournalFetal Diagnosis and Therapy
Pages (from-to)1-4
Number of pages4
ISSN1015-3837
DOIs
Publication statusPublished - 2018
Externally publishedYes

ID: 57106663